Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study
Background/Aims We aimed to assess the role of vitamin D supplementation in the response to pegylated interferon-α (PEG-IFN-α) plus ribavirin (RBV) treatment in patients with chronic hepatitis C (CHC). Methods Our study was a multi-center, randomized controlled trial in 11 hospitals. CHC patients we...
Main Authors: | Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2020-09-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.kjim.org/upload/pdf/kjim-2018-273.pdf |
Similar Items
-
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
by: Byung Chul You, et al.
Published: (2012-09-01) -
Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C
by: Baek Gyu Jun, et al.
Published: (2019-09-01) -
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
by: Hye Won Lee, et al.
Published: (2016-12-01) -
The Efficacy and Safety of Direct-acting Antiviral Treatment for Chronic Hepatitis C Patients: A Single Center Study
by: Seong Jun Park, et al.
Published: (2018-10-01) -
Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study)
by: Dae Won Jun, et al.
Published: (2018-01-01)